John Q. Trojanowski, MD,Tufts University, PhD, Tufts University 1976
Affiliations: | Pathology and Laboratory Medicine | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Neurodegenerative diseasesWebsite:
http://pathology.uphs.upenn.edu/Faculty/FacultyInfo.aspx?site=FacultyList&dept=Faculty&id=17800Google:
"John Trojanowski"Bio:
1998 AANP President
http://www.viswiki.com/en/John_Q._Trojanowski
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=4
Cross-listing: Neurotree - Neuropathology Tree
Children
Sign in to add traineeLawrence C. Kenyon | grad student | 1993-1996 | Penn (Neurotree) |
Mark Stuart Forman | post-doc | Penn (Neurotree) | |
Pallavi P. Gopal | post-doc | Penn (Neurotree) | |
Edward B. Lee | post-doc | Penn (Neurotree) | |
Peter T. Nelson | post-doc | Penn (Neurotree) | |
Daniel M. Skovronsky | post-doc | Penn (Neurotree) | |
Stefan Prokop | post-doc | 2015- | (Neurotree) |
Raymond Scott Turner | post-doc | 1992-1995 | Penn |
Kar-Ming Fung | post-doc | 1994-1995 | University of Oklahoma Health Sciences Center (Neurotree) |
Ian Victor Joseph Murray | post-doc | 1999-2003 | Indiana University of Pennsylvania (Neurotree) |
Benoit I. Giasson | post-doc | 2001-2003 | Penn (Neurotree) |
Maria Martinez-Lage | post-doc | 2007-2008 | Penn (Neuropathology Tree) |
Lionel Muller Igaz | post-doc | 2006-2010 | Penn (Neurotree) |
William T. Hu | post-doc | 2008-2010 | University of Pennsylvania School of Medicine |
Corey T. McMillan | research scientist | 2013- | Penn (Neurotree) |
Kelly R Miller | research scientist | 2015-2016 | Penn (Neurotree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Henderson MX, Sengupta M, Trojanowski JQ, et al. (2019) Alzheimer's disease tau is a prominent pathology in LRRK2 Parkinson's disease. Acta Neuropathologica Communications. 7: 183 |
Prokop S, Lee VMY, Trojanowski JQ. (2019) Neuroimmune interactions in Alzheimer's disease-New frontier with old challenges? Progress in Molecular Biology and Translational Science. 168: 183-201 |
Simuni T, Uribe L, Cho HR, et al. (2019) Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study. The Lancet. Neurology |
de Flores R, Berron D, Ding SL, et al. (2019) Characterization of hippocampal subfields using ex vivo MRI and histology data: Lessons for in vivo segmentation. Hippocampus |
Spotorno N, Hall S, Irwin DJ, et al. (2019) Diffusion Tensor MRI to Distinguish Progressive Supranuclear Palsy from α-Synucleinopathies. Radiology. 190406 |
Posavi M, Diaz-Ortiz M, Liu B, et al. (2019) Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis. Plos Medicine. 16: e1002931 |
Chu Y, Muller S, Tavares A, et al. (2019) Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes. Brain : a Journal of Neurology |
Caswell C, McMillan CT, Xie SX, et al. (2019) Genetic predictors of survival in behavioral variant frontotemporal degeneration. Neurology |
Uemura N, Uemura MT, Lo A, et al. (2019) Slow Progressive Accumulation of Oligodendroglial Alpha-Synuclein (α-Syn) Pathology in Synthetic α-Syn Fibril-Induced Mouse Models of Synucleinopathy. Journal of Neuropathology and Experimental Neurology |
Dumitrescu L, Barnes LL, Thambisetty M, et al. (2019) Sex differences in the genetic predictors of Alzheimer's pathology. Brain : a Journal of Neurology. 142: 2581-2589 |